Dr. Daniel Cameron

Lyme Disease Persister Cells: Why Bacteria Survive Antibiotics Lyme disease persister cells may explain why some patients remain ill even after antibiotic treatment. Experimental studies have demonstrated persistent infection of Borrelia burgdorferi in multiple animal models, including mice, dogs, and non-human primates. :contentReference[oaicite:0]{index=0} Some researchers argue that persistent infection may underlie chronic symptoms in Lyme […]

Extended Antibiotic Therapy for Lyme Disease: What Doctors Are Prescribing Extended antibiotic therapy for Lyme disease is more common in clinical practice than guidelines suggest. While the Infectious Diseases Society of America (IDSA) recommends a maximum of 21 days of antibiotics, the International Lyme and Associated Diseases Society (ILADS) supports individualized treatment based on patient

The Politics of Lyme Disease: Why Patients Are Caught in the Middle Lyme disease politics continue to shape how patients are diagnosed, treated, and ultimately understood. When competing medical viewpoints influence care, patients may be caught in the middle. Lyme in the Limelight, published by Hamodia, features interviews with leading voices in Lyme disease research,

Lyme Disease Clinical Trial Volunteers: Study on New Test (Now Completed) Lyme disease clinical trial volunteers play a critical role in advancing diagnostic research. This study, conducted by Dr. Daniel Cameron & Associates, focused on validating a newly developed Lyme disease test. Note: This study is now complete. Thank you to all who participated. Clinical

Lyme Carditis Misdiagnosis: A Physician’s Journey to Advocacy Lyme carditis misdiagnosis can have life-threatening consequences—even for experienced physicians. Dr. Neil Spector, a leading cancer researcher and oncologist, became a powerful advocate for Lyme disease patients after nearly losing his life to undiagnosed Lyme carditis. Update: Dr. Neil Spector has since passed away. He will be

Lyme Disease in Tennessee: Hundreds of Cases Missing from Reports Lyme disease Tennessee underreporting may be significant, with studies suggesting cases are far higher than official surveillance data. Researchers examining insurance claims and public health records identified major gaps in reported Lyme disease cases in Tennessee. A study using data from BlueCross BlueShield of Tennessee

Lyme Disease Testing Gap: 82% Untested in Non-Endemic Regions Most patients with symptoms consistent with Lyme disease are not tested in non-endemic regions—creating a major diagnostic gap. The Testing Gap in Non-Endemic Regions Researchers from Duke University Health System in North Carolina reviewed the medical records of 1,621 patients with a clinical history consistent with

Deer Ticks in Your Backyard: Study Shows Ongoing Risk Deer ticks backyard risk may be greater than many homeowners realize. Even if a yard is cleared of ticks, new research suggests they can quickly return through short-distance migration. “The increases in the geographic range and population sizes of several tick species… have resulted in dramatic

Chronic Lyme Disease: Patients Want Treatment, Not Management Chronic Lyme disease patients want to be treated—not simply managed. This distinction reflects a deeper divide in how clinicians approach persistent symptoms and patient care. :contentReference[oaicite:0]{index=0} The quote, “Minds are like parachutes. They only function when open,” attributed to Thomas Dewar, comes to mind when considering the

What Is That Smell? Lyme Disease and Heightened Sensitivity Lyme disease may affect more than joints, fatigue, and cognition—it may also alter the sense of smell. Some patients report a heightened sensitivity to odors, a condition known as hyperosmia, which is only beginning to be explored in Lyme disease. Changes in smell have long been